New drugs and vaccines for priority pathogens in antimicrobial resistance 2019
Basic Information
Antimicrobials are designed to kill or stop the growth of disease-causing pathogens, but many of them have become increasingly ineffective due to emerging resistance by the targeted bacteria, viruses, protozoa or fungi. Selection pressure naturally leads to the emergence of resistance whenever microbes are exposed to agents who are meant to kill them or inhibit their growth, and the potential spreading resistance can take days or years. Pathogens can also develop resistance to multiple agents, and as a result, very hard to control multi-drug resistant infections emerge and spread.
| Network | EDCTP2 | ||||||
| Website | https://www.edctp.org/call/new-drugs-and-vaccines-for-priority-pathogens-in-antimicrobial-resistance-2019/ | ||||||
| Aim of the joint call | The purpose of this call for proposals is to provide funding for clinical trials to be conducted in sub-Saharan Africa which aim to develop new or improved medicinal products (drugs and vaccines) or combinations thereof against pathogens from the WHO priority list that also fall within the scope of the EDCTP2 programme, specifically Campylobacter, Salmonella, Streptococcus pneumoniae, and Mycobacterium tuberculosis. | ||||||
| Type of joint call | One Stage - Call with no pre-proposals submission | ||||||
| Events |
|
||||||
| Is call co-funded? | No | ||||||
| Call follow up funding | n/a | ||||||
| Call reasons | n/a | ||||||
| Research fields |
|
||||||
| Type of research | n/a | ||||||
| Target groups | n/a | ||||||
| Participating networks | n/a |
Organisations Participating
No participating organisations found.